LOPEZ CARLOS LUIS enters NIAGEN BIOSCIENCE, INC. with 1.98K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 11/8/2024ACC: 0001628280-24-046708
Officer· SVP, General Counsel
Since Feb 2026
1.98K
Baseline shares
100% direct
1.98K
Direct ownership
1 position
75.88K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned1.98K
Total
1.98K direct1.98K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.98K | Direct |
| Total | 1.98K | 1.98K direct |
Derivative Holdings1
Employee Stock Options (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
75.88K
Shares owned
N/A
Exercise price
2.97
Expiration
—
Exercise window
—
Total
Underlying
75.88K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Options (right to buy) Direct | Common Stock | 2.97 | — | — | 75.88K | N/A |
| Total | 75.88K | 0.00 | ||||